<DOC>
	<DOCNO>NCT02111707</DOCNO>
	<brief_summary>To determine time administration indomethacin affect primary outcome post-ERCP pancreatitis ( PEP ) . Patients undergo ERCP randomly assign receive pre post-procedure rectal indomethacin prevent occurrence PEP .</brief_summary>
	<brief_title>Timing Indomethacin Administration Prevention Post-ERCP Pancreatitis ( PEP )</brief_title>
	<detailed_description />
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<criteria>All patient refer ERCP University Alberta Age great 18 year Ability provide write informed consent Acute pancreatitis Active peptic ulcer disease Rectal disease Aspirininduced asthma Nonsteroidal antiinflammatory drug ( NSAIDs ) induce hypersensitivity Pregnancy Breast feed Creatinine clearance &lt; 30 ml/min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>